|
|
|
市場調查報告書
全球連續式血糖監測系統(CGM)系統市場:開發平台分析，競爭環境，到2017年為止的市場預測
Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
| 出版商 |
GlobalData |
| 出版日期 |
2012年01月 |
商品編碼 |
228224 |
| 內容資訊 |
英文 Pages: 90 |
| 價格 |
|
|
全球連續式血糖監測系統(CGM)系統市場:開發平台分析，競爭環境，到2017年為止的市場預測 是由出版商GlobalData在2012年01月所出版的。
這份英文市場調查報告書包含Pages: 90 價格從美金3995起跳。
本報告提供連續式葡萄糖監視(CGM)設備的全球市場最新趨勢與未來展望相關分析，整體市場結構，全球·主要國家的市場趨勢(2003∼2017年的市場收益測量與預測等)，再加上主要企業簡介，各種產品的開發平台評估等資訊彙整，為您概述為以下內容。
第1章 目錄
第1章 簡介
第3章 疾病概要:糖尿病
- 糖尿病的種類
- 免疫學
- 美國的糖尿病得病率
- 英國的糖尿病得病率
- 日本的糖尿病得病率
- 印度的糖尿病得病率
- 中國的糖尿病得病率
- 美國的糖尿病得病率
- 診斷
- 空腹血糖(FPG)測試
- 口服葡萄糖耐受試驗(OGTT)
- 隨機血糖檢查
第4章 設備概要
第5章 全球市場特徵
- 市場收益實際成果值(2003∼2010年)
- 市場收益預測值(2010∼2017年)
- 主要趨勢
- 以低/非侵入式技術為基礎的替代技術
- 把握醫院用連續血糖監測系統的市場未滿足需求的企業
- 設備資料和可攜式·智慧·設備整合的趨勢
- 市場動態
第6章 各國市場的分析:市場收益(2003∼2017年)
- 市場收益實際成果值(美國，2003∼2010年)
- 市場收益預測值(美國，2010∼2017年)
- 市場收益實際成果值(加拿大，2003∼2010年)
- 市場收益預測值(加拿大，2010∼2017年)
- 市場收益實際成果值(英國，2003∼2010年)
- 市場收益預測值(英國，2010∼2017年)
- 市場收益實際成果值(德國，2003∼2010年)
- 市場收益預測值(德國，2010∼2017年)
- 市場收益實際成果值(法國，2003∼2010年)
- 市場收益預測值(法國，2010∼2017年)
- 市場收益實際成果值(義大利，2003∼2010年)
- 市場收益預測值(義大利，2010∼2017年)
- 市場收益實際成果值(西班牙，2003∼2010年)
- 市場收益預測值(西班牙，2010∼2017年)
- 市場收益實際成果值(日本，2003∼2010年)
- 市場收益預測值(日本，2010∼2017年)
- 市場收益實際成果值(中國，2003∼2010年)
- 市場收益預測值(中國，2010∼2017年)
- 市場收益實際成果值(印度，2003∼2010年)
- 市場收益預測值(印度，2010∼2017年)
- 市場收益實際成果值(澳洲，2003∼2010年)
- 市場收益預測值(澳洲，2010∼2017年)
- 市場收益實際成果值(巴西，2003∼2010年)
- 市場收益預測值(巴西，2010∼2017年)
第7章 策略性競爭力評估
- 主要企業
- Medtronic Inc.
- Dexcom
- Abbott Laboratories
第8章 策略性開發平台評估
- 臨床實驗階段的連續血糖監測系統(全11種)
- 認證階段的連續血糖監測系統(全1種)
- 初期處於開發階段的連續血糖監測系統(全4種)
- 全臨床階段的連續血糖監測系統(全2種)
第9章 策略性交易分析
- 合資經營財務融資(2008∼2011年)
- 夥伴關係(2008∼2011年)
- 股票上市(2008∼2011年)
- 發行公司債券(2008∼2011年)
- 企業收購(2008∼2011年11月)
- 資產交易(2008∼2011年11月)
- 主要交易
第10章 附錄
圖表一覽
Abstract
Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global Continuous Glucose Monitoring (CGM) Systems market. The report provides market landscape, competitive landscape and market trends information on the CGM Systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, China, India, Australia, and Brazil.
- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the CGM Systems market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Abbott Laboratories and DexCom.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the CGM Systems globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What's the next big thing in the CGM Systems market landscape? - Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global full- CGM Systems market and the factors shaping it.
TOC
1 Table of Contents
1 Table of Contents 3
- 1.1 List of Tables 5
- 1.2 List of Figures 7
2 Introduction and Overview 8
- 2.1 Introduction 8
- 2.2 GlobalData Report Guidance 8
3 Disease Overview - Diabetes 9
- 3.1 Types of Diabetes 9
- 3.1.1 Type 1 diabetes 9
- 3.1.2 Type 2 diabetes 9
- 3.1.3 Gestational diabetes 9
- 3.2 Epidemiology 9
- 3.2.1 Prevalence of Diabetes in the US 9
- 3.2.2 Prevalence of Diabetes in the UK 10
- 3.2.3 Prevalence of Diabetes in Japan 10
- 3.2.4 Prevalence of Diabetes in India 10
- 3.2.5 Prevalence of Diabetes in China 10
- 3.3 Diagnosis 10
- 3.3.1 Fasting Plasma Glucose (FPG) Test 10
- 3.3.2 Oral Glucose Tolerance Test (OGTT) 11
- 3.3.3 Random Plasma Glucose Test 11
4 Device Overview 12
- 4.1 Continuous Glucose Monitoring System 12
- 4.2 Continuous Glucose Monitoring System, Design 12
- 4.3 Continuous Glucose Monitoring Systems, Shortcomings 12
5 Continuous Glucose Monitoring Systems - Global Market Characterization 13
- 5.1 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Historic, 2003 - 2010 13
- 5.2 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Forecast, 2010 - 2017 14
- 5.3 Continuous Glucose Monitoring Systems Market, Key Trends 15
- 5.3.1 Alternative Technologies based on Less or Non-Invasive Techniques 15
- 5.3.2 Companies Identifying Unmet Market Need for Continuous Glucose Monitoring in Hospitals 16
- 5.3.3 Trend of Integration of the Device Data with Portable Smart Devices 17
- 5.4 Continuous Glucose Monitoring Systems, Market Dynamics 18
- 5.4.1 Market Drivers 18
- 5.4.2 Market Restraints 25
6 Continuous Glucose Monitoring Systems Market, Analysis by Country, Revenue ($m), 2003 - 2017 27
- 6.1 Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), Historic, 2003 - 2010 27
- 6.2 Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), Forecast, 2010 - 2017 28
- 6.3 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($'000), Historic, 2003 - 2010 29
- 6.4 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($'000), Forecast, 2010 - 2017 30
- 6.5 Continuous Glucose Monitoring Systems Market, The UK, Revenue ($'000), Historic, 2003 - 2010 31
- 6.6 Continuous Glucose Monitoring Systems Market, The UK, Revenue ($'000), Forecast, 2010 - 2017 32
- 6.7 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($'000), Historic, 2003 - 2010 33
- 6.8 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($'000), Forecast, 2010 - 2017 34
- 6.9 Continuous Glucose Monitoring Systems Market, France, Revenue ($), Historic, 2003 - 2010 35
- 6.10 Continuous Glucose Monitoring Systems Market, France, Revenue ($), Forecast, 2010 - 2017 36
- 6.11 Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), Historic, 2003 - 2010 37
- 6.12 Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), Forecast, 2010 - 2017 38
- 6.13 Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), Historic, 2003 - 2010 39
- 6.14 Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), Forecast, 2010 - 2017 40
- 6.15 Continuous Glucose Monitoring Systems Market, Japan, Revenue ($'000), Historic, 2010 41
- 6.16 Continuous Glucose Monitoring Systems Market, Japan, Revenue ($'000), Forecast, 2010 - 2017 42
- 6.17 Continuous Glucose Monitoring Systems Market, China, Revenue ($'000), Historic, 2004 - 2010 43
- 6.18 Continuous Glucose Monitoring Systems Market, China, Revenue ($'000), Forecast, 2010 - 2017 44
- 6.19 Continuous Glucose Monitoring Systems Market, India, Revenue ($'000), Historic, 2007 - 2010 45
- 6.20 Continuous Glucose Monitoring Systems Market, India, Revenue ($'000), Forecast, 2010 - 2017 46
- 6.21 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($'000), Historic, 2007 - 2010 47
- 6.22 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($'000), Forecast, 2010 - 2017 48
- 6.23 Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($'000), Historic, 2005 - 2010 49
- 6.24 Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($'000), Forecast, 2010 - 2017 50
7 Continuous Glucose Monitoring Systems Market - Strategic Competitive Assessment 51
- 7.1 Continuous Glucose Monitoring Systems, Key Market Participants 52
- 7.1.1 Medtronic Inc. 52
- 7.1.2 Dexcom 56
- 7.1.3 Abbott Laboratories 59
8 Continuous Glucose Monitoring Systems - Strategic Pipeline Assessment 61
- 8.1 Continuous Glucose Monitoring Systems in Clinical Development Stage 62
- 8.1.1 EyeSense, Blood Glucose Measurement Device, EyeSense GmbH 63
- 8.1.2 FAS Glucose Monitoring System, BioTex, Inc. 65
- 8.1.3 GluCath Intravascular Continuous Glucose Monitor, GluMetrics, Inc. 66
- 8.1.4 5th Generation Short-term Sensor, Dexcom 66
- 8.1.5 Continuous Glucose Monitor, MicroCHIPS, Inc. 66
- 8.1.6 Automated Blood Glucose Monitor, Luminous Medical 67
- 8.1.7 Automated Glucose Monitoring System, Cascade Metrix Inc. 69
- 8.1.8 CGM Biosensor, Invivosense ASA 70
- 8.1.9 CGM Sensor, CGM3 70
- 8.1.10 Continuous Intravascular Glucose Monitoring Device, Technomark Life Sciences Corporation 70
- 8.1.11 Eirus System, Dipylon Medical AB 72
- 8.2 Continuous Glucose Monitoring Systems in Approval Phase 73
- 8.2.1 Enlite Sensor, Medtronic, Inc. 73
- 8.3 Continuous Glucose Monitoring Systems in Early Development Stage 74
- 8.3.1 Biologue, ULTRADIAN Diagnostics. 74
- 8.3.2 Altea MicroPor Laser, GUIDED THERAPEUTICS, INC 75
- 8.3.3 Closed Loop Continuous Glucose Monitoring System, ConvaTec 75
- 8.3.4 GlucoChip, PositiveID Corporation 75
- 8.4 Continuous Glucose Monitoring Systems in Pre Clinical Development Stage 76
- 8.4.1 Electronic Mosquito, University of Calgary 76
- 8.4.2 GlucoReader, mobiLIFE 76
9 Continuous Glucose Monitoring Systems Market - Strategic Deals Analysis 77
- 9.1 Continuous Glucose Monitoring Devices Market, Venture Financing Deals, 2008 - 2011 78
- 9.2 Continuous Glucose Monitoring Devices Market, Partnerships, 2008 - 2011 80
- 9.3 Continuous Glucose Monitoring Devices Market, Equity Offering Deals, 2008 - 2011 81
- 9.4 Continuous Glucose Monitoring Devices Market, Debt Offering Deals, 2008 - 2011 82
- 9.5 Continuous Glucose Monitoring Devices Market, Acquisitions, 2008 - 2011* 83
- 9.6 Continuous Glucose Monitoring Devices Market, Asset Transaction Deals, 2008 - 2011* 83
- 9.7 Key Deals 83
- 9.7.1 Roche Diagnostics Enters into Research & Development and Distribution Agreement with Dexcom 83
- 9.7.2 Medtronic Acquires Glucose Monitoring Assets from PreciSense 84
- 9.7.3 Bayer HealthCare Completes Acquisition of iSense 84
- 9.7.4 Edwards Lifesciences Enters into an Agreement with Dexcom 84
10 Appendix 86
- 10.1 Market Definitions 86
- 10.1.1 Continuous Glucose Monitoring Systems 86
- 10.2 Acronyms 87
- 10.3 Research Methodology 88
- 10.3.1 Secondary Research 88
- 10.3.2 Primary Research 88
- 10.3.3 Models 89
- 10.3.4 Forecasts 89
- 10.3.5 Expert Panels 89
- 10.4 GlobalData Consulting 89
- 10.5 Contact Us 89
- 10.6 Disclaimer 90
- 10.7 Sources 90
List of Tables
1.1 List of Tables
- Table 1: Fasting Plasma Glucose Test 10
- Table 2: Oral Glucose Tolerance Test 11
- Table 3: Oral Glucose Tolerance Test for Gestational Diabetes 11
- Table 4: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2003 - 2010 13
- Table 5: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2010 - 2017 14
- Table 6: Continuous Glucose Monitoring, Alternate Technologies 16
- Table 7: Smart Phone Application for Diabetes Management, By Companies, 2011 17
- Table 8: Diabetes Prevalence (%) and Patient Population, by Country, 2011 19
- Table 9: Increase in Diabetes Patient Population (20-79 years) (%), by Region, 2011 - 2030 20
- Table 10: Insulin Pumps, Global, Revenue ($m), 2003 - 2010 22
- Table 11: CGM Coverage Policies of Private Insurers, the US, 2011 24
- Table 12: Average Selling Price Comparison ($) of Traditional and Continuous Glucose Meters, by Country, 2010 25
- Table 13: Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), 2003 - 2010 27
- Table 14: Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), 2010 - 2017 28
- Table 15: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($'000), 2003 - 2010 29
- Table 16: Continuous Glucose Monitoring Devices Systems Market, Canada, Revenue ($'000), 2010 - 2017 30
- Table 17: Continuous Glucose Monitoring Systems Market, The UK, Revenue ($'000), 2003 - 2010 31
- Table 18: Continuous Glucose Monitoring Systems Market, The UK, Revenue ($'000), 2010 - 2017 32
- Table 19: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($'000), 2003 - 2010 33
- Table 20: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($'000), 2010 - 2017 34
- Table 21: Continuous Glucose Monitoring Systems Market, France, Revenue ($), 2003 - 2010 35
- Table 22: Continuous Glucose Monitoring Systems Market, France, Revenue ($), 2010 - 2017 36
- Table 23: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), 2003 - 2010 37
- Table 24: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), 2010 - 2017 38
- Table 25: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), 2003 - 2010 39
- Table 26: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), 2010 - 2017 40
- Table 27: Continuous Glucose Monitoring Systems Market, Japan, Revenue ($'000), 2010 41
- Table 28: Continuous Glucose Monitoring Systems Market, Japan, Revenue ($'000), 2010 - 2017 42
- Table 29: Continuous Glucose Monitoring Devices Systems Market, China, Revenue ($'000), 2004 - 2010 43
- Table 30: Continuous Glucose Monitoring Systems Market, China, Revenue ($'000), 2010 - 2017 44
- Table 31: Continuous Glucose Monitoring Systems Market, India, Revenue ($'000), 2007 - 2010 45
- Table 32: Continuous Glucose Monitoring Systems Market, India, Revenue ($'000), 2010 - 2017 46
- Table 33: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($'000), 2007 - 2010 47
- Table 34: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($'000), 2010 - 2017 48
- Table 35: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($'000), 2005 - 2010 49
- Table 36: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($'000), 2010 - 2017 50
- Table 37: Continuous Glucose Monitoring Systems Market, Global, Company Share (%), Company Revenue ($m), 2010 51
- Table 38: Medtronic, Key Products 52
- Table 39: Medtronic, Alliances, 2007 - 2011 54
- Table 40: Dexcom, Key Products 56
- Table 41: Dexcom, Alliances, 2008 - 2011 58
- Table 42: Abbott Laboratories, Key Products 59
- Table 43: Continuous Glucose Monitoring Systems, Global Pipeline Products, 2011 61
- Table 44: List of Continuous Glucose Monitoring Systems in Clinical Development Stage 62
- Table 45: EyeSense Blood Glucose Measurement Device, Status 63
- Table 46: EyeSense Blood Glucose Measurement Device, Clinical Trial 64
- Table 47: FAS Glucose Monitoring System, Status 65
- Table 48: FAS Glucose Monitoring System, Clinical Trial 65
- Table 49: GluCath Intravascular Continuous Glucose Monitor, Status 66
- Table 50: 5th Generation Short-term Sensor, Status 66
- Table 51: Continuous Glucose Monitor, Status 67
- Table 52: Automated Blood Glucose Monitor, Product Status 67
- Table 53: Automated Blood Glucose Monitor, Clinical Trial 68
- Table 54: Automated Glucose Monitoring System, Status 69
- Table 55: Automated Glucose Monitoring System, Clinical Trial 69
- Table 56: CGM Biosensor, Status 70
- Table 57: CGM Sensor, Status 70
- Table 58: Continuous Intravascular Glucose Monitoring Device, Status 70
- Table 59: Continuous Intravascular Glucose Monitoring Device, Clinical Trial 71
- Table 60: Eirus System, Status 72
- Table 61: List of Continuous Glucose Monitoring Systems in Approval Process 73
- Table 62: Enlite Sensor, Status 73
- Table 63: List of Continuous Glucose Monitoring Systems in Early Development Stage 74
- Table 64: Biologue, Status 74
- Table 65: Altea MicroPor Laser, Status 75
- Table 66: Closed Loop Continuous Glucose Monitoring System, Status 75
- Table 67: Closed Loop Continuous Glucose Monitoring System, Status 75
- Table 68: List of Continuous Glucose Monitoring Systems in Pre-Clinical Stage 76
- Table 69: Electronic Mosquito, Status 76
- Table 70: GlucoReader, Status 76
- Table 71: Continuous Glucose Monitoring Systems Market, Deals, 2008-2011* 77
- Table 72: Continuous Glucose Monitoring Devices Market, Venture Financing Deals, 2008 - 2011* 78
- Table 73: Continuous Glucose Monitoring Devices Market, Partnerships, 2008 - 2011* 80
- Table 74: Continuous Glucose Monitoring Devices Market, Equity Offering Deals, 2008 - 2011* 81
- Table 75: Continuous Glucose Monitoring Devices Market, Debt Offering Deals, 2008 - 2011* 82
- Table 76: Continuous Glucose Monitoring Devices Market, Acquisitions, 2008 - 2011* 83
- Table 77: Continuous Glucose Monitoring Devices Market, Asset Transaction Deals, 2008 - 2011* 83
List of Figures
1.2 List of Figures
- Figure 1: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2003 - 2010 13
- Figure 2: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2010 - 2017 14
- Figure 3: Continuous Glucose Monitoring Systems, Market Dynamics 18
- Figure 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011 18
- Figure 5: Insulin Pumps, Global, Revenue ($m), 2003 - 2010 22
- Figure 6: Continuous Glucose Monitoring Systems, the US vs. Other Countries, Revenues (% contribution), 2010 23
- Figure 7: Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), 2003 - 2010 27
- Figure 8: Continuous Glucose Monitoring Systems Market, The US, Revenue ($m), 2010 - 2017 28
- Figure 9: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($'000), 2003 - 2010 29
- Figure 10: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($'000), 2010 - 2017 30
- Figure 11: Continuous Glucose Monitoring Systems Market, The UK, Revenue ($'000), 2003 - 2010 31
- Figure 12: Continuous Glucose Monitoring Systems Market, The UK, Revenue ($'000), 2010 - 2017 32
- Figure 13: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($'000), 2003 - 2010 33
- Figure 14: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($'000), 2010 - 2017 34
- Figure 15: Continuous Glucose Monitoring Systems Market, France, Revenue ($), 2003 - 2010 35
- Figure 16: Continuous Glucose Monitoring Systems Market, France, Revenue ($), 2010 - 2017 36
- Figure 17: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), 2003 - 2010 37
- Figure 18: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($), 2010 - 2017 38
- Figure 19: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), 2003 - 2010 39
- Figure 20: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($), 2010 - 2017 40
- Figure 21: Continuous Glucose Monitoring Systems Market, Japan, Revenue ($'000), 2010 41
- Figure 22: Continuous Glucose Monitoring Systems Market, Japan, Revenue ($'000), 2010 - 2017 42
- Figure 23: Continuous Glucose Monitoring Systems Market, China, Revenue ($'000), 2004 - 2010 43
- Figure 24: Continuous Glucose Monitoring Systems Market, China, Revenue ($'000), 2010 - 2017 44
- Figure 25: Continuous Glucose Monitoring Systems Market, India, Revenue ($'000), 2007 - 2010 45
- Figure 26: Continuous Glucose Monitoring Systems Market, India, Revenue ($'000), 2010 - 2017 46
- Figure 27: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($'000), 2007 - 2010 47
- Figure 28: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($'000), 2010 - 2017 48
- Figure 29: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($'000), 2005 - 2010 49
- Figure 30: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($'000), 2010 - 2017 50
- Figure 31: Continuous Glucose Monitoring Systems Market, Global, Company Share (%), 2010 51
Figure 32: Medtronic, SWOT Analysis 53
Figure 33: Dexcom, SWOT Analysis 56
Figure 34: Abbott Laboratories, SWOT Analysis 59
- Figure 35: Continuous Glucose Monitoring Systems, Global Pipeline Products, 2011 61
- Figure 36: Continuous Glucose Monitoring Systems Market, Deals, 2008-2011* 77
|
 |
